Diagnostic Ability of Endoscopic Ultrasound-Guided Tissue Acquisition Using 19-Gauge Fine-Needle Biopsy Needle for Abdominal Lesions
Attempts at performing endoscopic ultrasound-guided tissue acquisition (EUS-TA) with a 19G needle are increasing because histological diagnosis and comprehensive genomic profiling are a necessity. However, the diagnostic ability of the 19G fine-needle biopsy (FNB) needle, especially the third-generation FNB needle, is unclear and has been retrospectively reviewed. The 19G TopGain needle was used in 147 patients and 160 lesions between September 2020 and December 2021. The technical success rate of the biopsies was 99.4% (159/160). The early adverse event rate was 4.1% (6/147), and moderate or severe adverse event rate occurrence was 2.0% (3/147). The sensitivity, specificity, and accuracy of the 19G TopGain needle for 157 lesions with a confirmed diagnosis were 96.7%, 100%, and 96.8%, respectively. Rescue EUS-TA using the 19G TopGain needle was performed for nine lesions, and a successful diagnosis was made in six of these lesions (66.7%). The diagnostic ability of EUS-TA using the third-generation 19G TopGain needle was favorable. However, the use of 19G FNB needles may increase adverse events. Therefore, EUS-TA with a 19G FNB needle is mainly indicated in lesions where comprehensive genomic profiling may be necessary or the diagnosis could not be determined via EUS-TA using the 22G needle.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Diagnostics (Basel, Switzerland) - 13(2023), 3 vom: 26. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Takeshita, Kotaro [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
19-gauge needle |
|---|
| Anmerkungen: |
Date Revised 13.02.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3390/diagnostics13030450 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352762756 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352762756 | ||
| 003 | DE-627 | ||
| 005 | 20231226054448.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/diagnostics13030450 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1175.xml |
| 035 | |a (DE-627)NLM352762756 | ||
| 035 | |a (NLM)36766558 | ||
| 035 | |a (PII)450 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Takeshita, Kotaro |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Diagnostic Ability of Endoscopic Ultrasound-Guided Tissue Acquisition Using 19-Gauge Fine-Needle Biopsy Needle for Abdominal Lesions |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.02.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Attempts at performing endoscopic ultrasound-guided tissue acquisition (EUS-TA) with a 19G needle are increasing because histological diagnosis and comprehensive genomic profiling are a necessity. However, the diagnostic ability of the 19G fine-needle biopsy (FNB) needle, especially the third-generation FNB needle, is unclear and has been retrospectively reviewed. The 19G TopGain needle was used in 147 patients and 160 lesions between September 2020 and December 2021. The technical success rate of the biopsies was 99.4% (159/160). The early adverse event rate was 4.1% (6/147), and moderate or severe adverse event rate occurrence was 2.0% (3/147). The sensitivity, specificity, and accuracy of the 19G TopGain needle for 157 lesions with a confirmed diagnosis were 96.7%, 100%, and 96.8%, respectively. Rescue EUS-TA using the 19G TopGain needle was performed for nine lesions, and a successful diagnosis was made in six of these lesions (66.7%). The diagnostic ability of EUS-TA using the third-generation 19G TopGain needle was favorable. However, the use of 19G FNB needles may increase adverse events. Therefore, EUS-TA with a 19G FNB needle is mainly indicated in lesions where comprehensive genomic profiling may be necessary or the diagnosis could not be determined via EUS-TA using the 22G needle | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a 19-gauge needle | |
| 650 | 4 | |a Franseen needle | |
| 650 | 4 | |a comprehensive genomic profiling | |
| 650 | 4 | |a diagnostic ability | |
| 650 | 4 | |a endoscopic ultrasound-guided tissue acquisition | |
| 650 | 4 | |a fine-needle biopsy | |
| 650 | 4 | |a liver | |
| 650 | 4 | |a lymph node | |
| 650 | 4 | |a pancreatic cancer | |
| 700 | 1 | |a Hijioka, Susumu |e verfasserin |4 aut | |
| 700 | 1 | |a Nagashio, Yoshikuni |e verfasserin |4 aut | |
| 700 | 1 | |a Maruki, Yuta |e verfasserin |4 aut | |
| 700 | 1 | |a Kawasaki, Yuki |e verfasserin |4 aut | |
| 700 | 1 | |a Maehara, Kosuke |e verfasserin |4 aut | |
| 700 | 1 | |a Murashima, Yumi |e verfasserin |4 aut | |
| 700 | 1 | |a Okada, Mao |e verfasserin |4 aut | |
| 700 | 1 | |a Ikeda, Go |e verfasserin |4 aut | |
| 700 | 1 | |a Yamada, Natsumi |e verfasserin |4 aut | |
| 700 | 1 | |a Takasaki, Tetsuro |e verfasserin |4 aut | |
| 700 | 1 | |a Agarie, Daiki |e verfasserin |4 aut | |
| 700 | 1 | |a Hara, Hidenobu |e verfasserin |4 aut | |
| 700 | 1 | |a Hagiwara, Yuya |e verfasserin |4 aut | |
| 700 | 1 | |a Okamoto, Kohei |e verfasserin |4 aut | |
| 700 | 1 | |a Yamashige, Daiki |e verfasserin |4 aut | |
| 700 | 1 | |a Ohba, Akihiro |e verfasserin |4 aut | |
| 700 | 1 | |a Kondo, Shunsuke |e verfasserin |4 aut | |
| 700 | 1 | |a Morizane, Chigusa |e verfasserin |4 aut | |
| 700 | 1 | |a Ueno, Hideki |e verfasserin |4 aut | |
| 700 | 1 | |a Saito, Yutaka |e verfasserin |4 aut | |
| 700 | 1 | |a Ohe, Yuichiro |e verfasserin |4 aut | |
| 700 | 1 | |a Okusaka, Takuji |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diagnostics (Basel, Switzerland) |d 2011 |g 13(2023), 3 vom: 26. Jan. |w (DE-627)NLM250111136 |x 2075-4418 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2023 |g number:3 |g day:26 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3390/diagnostics13030450 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2023 |e 3 |b 26 |c 01 | ||